prednisolone has been researched along with cholecalciferol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Felice, LJ; Hegstad, RL; Murphy, MJ; Pertile, T; Scheftel, J; Setzer, S; Walser, M | 1 |
| Yamagishi, M; Yoshida, Y | 1 |
| Hodges, NH; Jibani, M | 1 |
| Lukert, BP; Mawer, EB; Stanbury, SW | 1 |
| Clemens, TL; Fraher, LJ; O'Riordan, JL; Sandler, LM; Smith, R; Winearls, CG | 1 |
| Aerssens, J; Bramm, E; Dequeker, J; Geusens, P; Talalaj, M; Van Audekercke, R; Van Vlasselaer, P | 1 |
| Amosov, VI; Ememl'ianov, AV; Murzin, BA; Shevelev, SE | 1 |
| Fujigaki, Y; Fukasawa, H; Hishida, A; Yonemura, K | 1 |
| Okada, N | 1 |
| Abramowicz, D; Broeders, N; Gervy, C; Moreno-Reyes, R; Stallenberg, B; Wissing, KM | 1 |
| Soen, S | 2 |
| Lavender, TW; Martineau, AR; Quinton, R; Schwab, U | 1 |
| Hagiwara, F; Hirose, J; Juji, T; Kadono, Y; Matsudaira, K; Matsui, T; Matsumoto, T; Mori, T; Nagase, Y; Nakayama, H; Nishino, J; Omata, Y; Tanaka, S; Tohma, S; Yasui, T | 1 |
| Baerwald, C; Krasselt, M | 1 |
| Lisakovska, OO; Mazanova, AO; Riasniy, VM; Shymanskyy, IO; Veliky, MM | 1 |
| Ghosoun, N; Kamhieh-Milz, J; Salama, A; Sterzer, V | 1 |
| Handgretinger, R; Hirschberg, I; Holzer, U; Reinhardt-Heller, K; Vogl, T | 1 |
| Fujimoto, N; Ishikawa, T; Matsuo, S; Munetsugu, T; Nishizawa, A; Satoh, T; Yamazaki, Y | 1 |
4 review(s) available for prednisolone and cholecalciferol
| Article | Year |
|---|---|
[Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].
Topics: Aged; Alendronate; Anti-Inflammatory Agents; Bone Density; Cholecalciferol; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Lumbar Vertebrae; Male; Meta-Analysis as Topic; Middle Aged; Osteoporosis; Prednisolone; Skin Diseases | 2004 |
[Management of glucocorticoid-induced osteoporosis].
Topics: Bone and Bones; Bone Density; Cholecalciferol; Diphosphonates; Fractures, Bone; Glucocorticoids; Humans; Osteocalcin; Osteoporosis; Practice Guidelines as Topic; Prednisolone; Randomized Controlled Trials as Topic; Risk; Vitamin K 2 | 2005 |
[Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Topics: Bone Density; Bone Density Conservation Agents; Cholecalciferol; Diphosphonates; Evidence-Based Medicine; Fractures, Bone; Glucocorticoids; Humans; Japan; Osteoporosis; Practice Guidelines as Topic; Prednisolone; Time Factors; Vitamin K 2 | 2006 |
[An update on glucocorticoid-induced osteoporosis].
Topics: Administration, Oral; Bone Density; Calcium, Dietary; Cholecalciferol; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Long-Term Care; Osteoporosis; Osteoporotic Fractures; Prednisolone; Risk; Young Adult | 2016 |
3 trial(s) available for prednisolone and cholecalciferol
| Article | Year |
|---|---|
Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
Topics: Adolescent; Adult; Bone Density; Bone Resorption; Cholecalciferol; Chronic Disease; Female; Glomerulonephritis; Glucocorticoids; Humans; Lumbar Vertebrae; Male; Middle Aged; Parathyroid Hormone; Prednisolone; Prospective Studies; Vitamin K 2 | 2004 |
A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids.
Topics: Adult; Aged; Bone Density; Calcium; Cholecalciferol; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Parathyroid Hormone; Prednisolone; Prospective Studies; Risk Factors | 2005 |
Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients.
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Cholecalciferol; Diphosphonates; Female; Femur Neck; Humans; Middle Aged; Postmenopause; Prednisolone; Radiography; Spinal Fractures | 2014 |
13 other study(ies) available for prednisolone and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Elevated 25-hydroxy and normal 1,25-dihydroxy cholecalciferol serum concentrations in a successfully-treated case of vitamin D3 toxicosis in a dog.
Topics: Animals; Calcifediol; Calcitonin; Calcitriol; Calcium; Cholecalciferol; Dog Diseases; Dogs; Female; Prednisolone; Rodenticides | 1991 |
[Prednisolone, 1 alpha hydroxyvitamin D3 and androgens in the management in patients with refractory anemias].
Topics: Administration, Oral; Androgens; Androstanols; Anemia, Refractory; Cholecalciferol; Drug Administration Schedule; Drug Therapy, Combination; Humans; Oxymetholone; Prednisolone | 1988 |
Prolonged hypercalcaemia after industrial exposure to vitamin D3.
Topics: Adult; Chemical Industry; Cholecalciferol; Cholestyramine Resin; Dexamethasone; Humans; Hydrocortisone; Hypercalcemia; Male; Occupational Diseases; Prednisolone | 1985 |
Vitamin D and intestinal transport of calcium: effects of prednisolone.
Topics: Animals; Bone and Bones; Calcium; Calcium Isotopes; Carbon Isotopes; Cholecalciferol; Chromatography; Female; Hydroxycholecalciferols; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Kidney; Liver; Prednisolone; Rats | 1973 |
Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
Topics: Adult; Aged; Calcifediol; Calcitriol; Cholecalciferol; Humans; Hydrocortisone; Hypercalcemia; Light; Male; Metabolic Clearance Rate; Middle Aged; Prednisolone; Sarcoidosis | 1984 |
Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Matrix; Calcification, Physiologic; Calcium; Calcium, Dietary; Cholecalciferol; Drug Synergism; Female; Femur; Insulin-Like Growth Factor I; Male; Osteocalcin; Phosphorus; Prednisolone; Random Allocation; Rats; Rats, Sprague-Dawley; Sex Characteristics; Transforming Growth Factor beta; Weight-Bearing | 1994 |
[Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
Topics: Adult; Asthma; Calcifediol; Calcium; Calcium Carbonate; Cholecalciferol; Drug Combinations; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteocalcin; Osteoporosis; Prednisolone; Radioimmunoassay; Spectrophotometry, Atomic; Substance-Related Disorders; Treatment Outcome | 1999 |
Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D.
Topics: Antitubercular Agents; Biomarkers; Calcifediol; Calcitriol; Calcium; Cholecalciferol; Dietary Supplements; Glucocorticoids; Humans; Hypercalcemia; Male; Middle Aged; Prednisolone; Severity of Illness Index; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary; Vitamin D Deficiency | 2012 |
Effects of vitamin D3 and vitamin E on prednisolone-induced alterations of phagocyte function.
Topics: Animals; Cholecalciferol; Escherichia coli; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Monocytes; Neutrophils; Phagocytosis; Prednisolone; Rats; Rats, Wistar; Reactive Oxygen Species; Vitamin E | 2016 |
Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP).
Topics: Adult; Aged; B-Cell Activating Factor; Binding Sites; Cholecalciferol; Drug Therapy, Combination; Female; Gene Expression Regulation; Glucocorticoids; Humans; Male; Middle Aged; Prednisolone; Promoter Regions, Genetic; Purpura, Thrombocytopenic, Idiopathic; Receptors, Glucocorticoid; Tumor Necrosis Factor Ligand Superfamily Member 13; Vitamins | 2018 |
Characterization of monocyte subtypes regarding their phenotype and development in the context of graft-versus-host disease.
Topics: Adult; Aged; Cells, Cultured; Cholecalciferol; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HSP70 Heat-Shock Proteins; Humans; Immunophenotyping; Immunosuppressive Agents; Interleukin-6; Male; Middle Aged; Monocytes; Prednisolone; Th17 Cells; Tumor Necrosis Factor-alpha; Young Adult | 2018 |
Pustular psoriasis with severe liver dysfunction: psoriasis-specific immune hepatitis?
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cholecalciferol; Dermatologic Agents; Hepatitis; Humans; Male; Middle Aged; Prednisolone; Psoriasis | 2021 |